Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Hypoactive Sexual Desire Disorder
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
FDA Approves New Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women
U.S. Food & Drug Administration
PR-M06-19-NI-044
Jun 25, 2019
